| Disease |
Global estimated prevalence |
Global estimated deaths, 2014 |
Vaccine type |
Dose up to 35 months of age |
Averted deaths from immunization up to 2014 |
Major challenges and issues in immunization |
References |
| Poliomyelitis |
359 reported cases except endemicity in Pakistan and Afghanistan with estimate 200 000 new cases every year |
NA |
Inactivated poliovirus (IPV) |
3 |
More than 13 million people |
Political instability, insecurity and other anecdotes
-Weak country leadership commitment, local accountability and stewardship
-Weak capacity of health workers at all levels |
[2] |
| Measles, Mumps and Rubella |
18.7 million infants worldwide |
114 900 measles deaths globally |
measles-mumps-rubella (MMR), |
1 |
2 to 3 million deaths per year |
Weak logistics and fragmentation of planning
-Unproductive immunization data management and use to inform programme innovations |
[1,29] |
| Varicella |
4.2 million |
4200 deaths |
varicella-zoster virus (VZB), |
1 |
2.5 million child deaths per year |
Shortages cold supply chain management and logistics systems of vaccines including other essential commodities
-Limited healthcare service delivery |
[2,4] |
| Hepatitis B |
240 million people |
780 000- 1 million deaths/year |
hepatitis B virus (HBV), |
3 |
3.7 million future deaths per year |
| Influenza b |
3 to 5 million cases |
250 000 to 500 000 deaths |
Haemophilus influenza type b (Hib) |
3 |
NA |
Limited immunization spots and outreach sites
-Fragile communication strategies at all levels |
[1,4] |
| Diphtheria, Tenanus and Pertussis |
18.7 million infants |
2 to 3 million deaths every year |
Diphtheria, Tetanus and acellular Tertussis (DTaP) vaccine |
4
and at 13-15 years old) |
2.5 million child deaths every year |
Scarce availability of vaccines storage capacity at all levels in most countries,
-Lack of funding for vaccine distribution in most remotes rural settings
-Health system dysfunctionment |
[1,4] |
